Disease/Infection News

RSS

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.

18 Jun 2014

Entomologists develop chromosome map to find ways to prevent dengue fever, yellow fever

Virginia Tech entomologists have developed a chromosome map for about half of the genome of the mosquito Aedes agypti, the major carrier of dengue fever and yellow fever.

18 Jun 2014

Researchers identify six gene loci associated with pulmonary diseases

In their investigations or so-called genome-wide association studies, the team of researchers compared the genetic profile of study participants to the forced vital capacity (FVC), a volume parameter of lung function.

18 Jun 2014

A new approach to treating whipworm infections

Researchers have deduced essential biological and genetic information from the genome sequence of the whipworm, an intestinal parasitic worm that infects hundreds of millions of people in developing countries.

18 Jun 2014

Researchers map risk of H7N9 bird flu infection in markets across Asia

Led by Marius Gilbert - Interfaculty School of Bioengineering, Université libre de Bruxelles - an international researcher team maps the risk of H7N9 bird flu infection in markets across Asia. The identification of high risk areas should helping to restrict the spread of this new disease.

18 Jun 2014

Genomic study reveals striking contrasts that may aid disease prevention

Virginia Tech entomologists have developed a chromosome map for about half of the genome of the mosquito Aedes agypti, the major carrier of dengue fever and yellow fever.

17 Jun 2014

Gluten-free diet can improve 'brain fog' in individuals with celiac disease

Individuals with celiac disease often experience 'brain fog' in addition to intestinal problems, but a new study shows that adhering to a gluten-free diet can lead to improvements in cognition that correlate with the extent of intestinal healing.

17 Jun 2014

C. difficile bacteria pose major health threat without proper infection prevention in hospitals, homes

Without proper infection prevention in hospitals, and now homes, the Clostridium difficile bacteria poses a major health threat, cautions a Case Western Reserve University infection control researcher.

17 Jun 2014

Loyola celebrates National HIV Testing Day by offering free HIV testing to patients

June 27 is National HIV Testing Day and Loyola University Health System will celebrate as they do every day - by offering free HIV testing to patients in the emergency department and at select immediate care centers.

17 Jun 2014

New study examines rising disparities in AIDS deaths in NYC

Between 2005 and 2012, the percentage of city AIDS deaths in the Bronx and Brooklyn climbed significantly while deaths of people with AIDS in Manhattan significantly decreased, according to a new study released today by Health People: Community Preventive Health Institute.

17 Jun 2014

Chikungunya virus puts some regions at risk of epidemic

For the first time, University of Texas Medical Branch at Galveston researchers were able to predict further adaptations of the chikungunya virus that recently spread from Africa to several continents that will likely result in even more efficient transmission and infection of more people by this virus strain.

17 Jun 2014

Predicting dengue fever in Brazil: an interview with Dr. Rachel Lowe, Catalan Institute for Climate Sciences (IC3)

Dengue is a mosquito-transmitted viral infection. The disease is widespread in tropical and sub-tropical climates and most commonly found in urban areas. Around half of the world's population are now estimated to live in dengue endemic regions.

16 Jun 2014

Infliximab biosimilar CT-P13 improves disease activity in patients with Ankylosing Spondylitis

New data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) show that the newly-approved infliximab biosimilar CT-P13 achieves statistically similar improvements in disease activity, disability and mobility in patients with Ankylosing Spondylitis (AS) compared to its original reference product infliximab (INX).

13 Jun 2014

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).

12 Jun 2014

Findings provide new strategy for developing safe, effective vaccine against strep throat

An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, have identified the genes encoding a molecule that famously defines Group A Streptococcus (strep), a pathogenic bacterial species responsible for more than 700 million infections worldwide each year.

12 Jun 2014

Back App: A training apparatus for Sitting Disease

Scientific research is increasingly showing strong links between spending too much time sitting and the development of severe long and short term health problems.

12 Jun 2014

AtomoRapid blood test device named Best in Show at 2014 MDEA program

Atomo Diagnostics' multi-award winning AtomoRapid™ HIV last night was awarded Best in Show, and the winner of the In Vitro Diagnostics Category, at the 17th Medical Design Excellence Awards (MDEA), held in New York.

12 Jun 2014

Ferrer recruits first patient in second phase III trial of Ozenoxacin for treatment of impetigo

Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatric patients with impetigo. The study is scheduled to complete in Q1, 2015.

12 Jun 2014

TxCell receives Certificate of GMP compliance for cell therapy manufacturing facility in France

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it has been granted Certificate of Good Manufacturing Practice (GMP) compliance for its cell therapy manufacturing facility in Besançon, France.

12 Jun 2014

Coordinated intervention focused on long-term care facilities reduces CRE cases

A new study found a nationwide effort to control carbapenem-resistant Enterobacteriaceae (CRE) in Israel reduced CRE cases by improving compliance of infection control standards and using a coordinated intervention focused on long-term care facilities.

12 Jun 2014

Disease/Infection News

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Entomologists develop chromosome map to find ways to prevent dengue fever, yellow fever

Researchers identify six gene loci associated with pulmonary diseases

A new approach to treating whipworm infections

Researchers map risk of H7N9 bird flu infection in markets across Asia

Genomic study reveals striking contrasts that may aid disease prevention

Gluten-free diet can improve 'brain fog' in individuals with celiac disease

C. difficile bacteria pose major health threat without proper infection prevention in hospitals, homes

Loyola celebrates National HIV Testing Day by offering free HIV testing to patients

New study examines rising disparities in AIDS deaths in NYC

Chikungunya virus puts some regions at risk of epidemic

Predicting dengue fever in Brazil: an interview with Dr. Rachel Lowe, Catalan Institute for Climate Sciences (IC3)

Infliximab biosimilar CT-P13 improves disease activity in patients with Ankylosing Spondylitis

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Findings provide new strategy for developing safe, effective vaccine against strep throat

Back App: A training apparatus for Sitting Disease

AtomoRapid blood test device named Best in Show at 2014 MDEA program

Ferrer recruits first patient in second phase III trial of Ozenoxacin for treatment of impetigo

TxCell receives Certificate of GMP compliance for cell therapy manufacturing facility in France

Coordinated intervention focused on long-term care facilities reduces CRE cases

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News